Marshall Wace
IFRX icon

Marshall Wace’s InflaRx IFRX Stock Holding History

Marshall Wace’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$493K Buy
554,364
+274,324
+98% +$259K ﹤0.01% 2464
2025
Q4 		$283K Sell
280,040
-27,042
-9% -$33.6K ﹤0.01% 2472
2025
Q3 		$411K Buy
+307,082
New +$326K ﹤0.01% 2300
2024
Q3 		– Sell
-33,824
Closed -$58.9K – 2709
2024
Q2 		$58.9K Sell
33,824
-47,995
-59% -$70.4K ﹤0.01% 2435
2024
Q1 		$126K Buy
81,819
+45,818
+127% +$74.9K ﹤0.01% 2284
2023
Q4 		$58.7K Buy
36,001
+23,500
+188% +$40.3K ﹤0.01% 2070
2023
Q3 		$37.3K Buy
+12,501
New +$47.6K ﹤0.01% 2100
2022
Q2 		– Sell
-34,353
Closed -$63K – 3628
2022
Q1 		$63K Buy
+34,353
New +$107K ﹤0.01% 3232

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return

Marshall Wace's IFRX Position: Q1 2026 in Review

Marshall Wace increased its InflaRx (IFRX) stake by 98% in Q1 2026, buying an estimated $259K and bringing the position to 554,364 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #2464.

Marshall Wace first reported a position in IFRX in Q1 2022 and has held it in 8 quarters since. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

  • Marshall Wace held 554,364 shares of InflaRx worth $493K as of Q1 2026.
  • Marshall Wace bought 274,324 InflaRx shares in Q1 2026, an estimated $259K.
  • InflaRx made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2464 holding.
  • Marshall Wace first reported a position in InflaRx in Q1 2022 and has held it in 8 quarters since.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.